Imaging analytics software gets FDA clearance

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

HealthMyne, an imaging informatics company, has received 510(k) clearance from the FDA for its analytics software package designed to provide radiologists with significant workflow efficiencies related to oncology cases, as well as advanced decision support.

New image characterization and tracking features are now provided in a quantitative imaging dashboard, which includes time-sequenced Epic EHR information. The analytics software also offers tracking of a nodule or tumor over multiple, spatially registered imaging studies. This can reveal information about whether the structure is growing, shrinking or stable to aid in tailoring treatment.

Cancer screening programs also can benefit from nodule characterization. The HealthMyne software automatically identifies nodule growth in patients participating in lung cancer screening programs. As an indicator of potential nodule malignancy, patients with such growth would warrant extra scrutiny.